Please ensure Javascript is enabled for purposes of website accessibility

Better Buy: Baker Hughes vs. Core Laboratories N.V.

By Matthew DiLallo – Apr 29, 2019 at 11:03AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

These two oil-field services companies go head-to-head.

Oil prices have been scorching hot this year. That rally has fueled big gains in most oil stocks, including shares of service companies Core Laboratories (CLB 0.83%) and Baker Hughes (BKR 0.72%), which have both rallied more than 10% so far this year.

That uptick in the oil market likely has investors wondering which company is the better one to buy right now. Here's a look at how they stack up.

Pump jack and engineer on a winter sunset sky background.

Image source: Getty Images.

Drilling down into the margins

While Baker Hughes and Core Labs both operate in the oil-field service sector, they're very different companies. Baker Hughes is a giant in the industry and is currently the third largest oil services company by revenue, behind Schlumberger and Halliburton. Core Labs, on the other hand, focuses on analyzing core samples and other data to help oil companies optimize the development of underground reservoirs. Because of their differences in size and scope, they don't make money the same way.

Baker Hughes provides a variety of specialized services to help oil companies find and extract oil and gas. The company not only needs to employ a large workforce to carry out these activities, but it must invest in equipment and buy consumable products like drill bits to complete work for its customers. These costs add up, which can weigh on margins, especially during challenging times in the oil market. When oil prices crashed during last year's fourth quarter, for instance, Baker Hughes' margins were in the low single digits.

Core Labs mainly does laboratory analysis, and thus it doesn't have to spend capital on expensive equipment. That's one reason Core earns the highest returns on invested capital in the oil-field service sector. In addition, this work carries higher margins, which tend to remain healthy even during tough times. That was the case in the most recently completed first quarter when Core's margins were 19%. Because Core earns high margins and doesn't need to invest much capital into its business, the company has consistently generated free cash flow. It recently notched its 70th straight quarter of producing free cash. Contrast this with Baker Hughes, which didn't produce any free cash in 2017.

Comparing their financial profiles

Since Core Labs doesn't need to invest much capital into buying new equipment, the company doesn't have a lot of debt. It ended the first quarter with about $295 million in debt. That's a very manageable level for a $3 billion company, especially one that consistently produces free cash flow.

Baker Hughes, on the other hand, ended last year with more than $7 billion in debt. While that's a manageable level for a $47 billion company, it's a much higher percentage of its total value compared to Core. That higher debt level is a concern since it could put pressure on the company's share price during periods of market turmoil.

A quick look at the valuations

While shares of both oil-field service companies are up double digits this year, Baker Hughes has surged nearly 20%, outperforming Core Labs' roughly 10% rally. The main factor holding back Core Labs was its lackluster second-quarter guidance, which recently caused its stock to slump 10%.

Shares of Core currently sell for 32 times expected earnings over the next 12 months. That's a higher forward earnings multiple than Baker Hughes' 25. However, it's harder to justify Baker Hughes' valuation than it is Core's since the later has very high margins and a top-tier balance sheet.

Verdict: Core Labs is the better buy

Core Labs' recent sell-off makes it a more compelling buy these days. Its valuation looks much more attractive considering that the company produces margins that wouldn't seem out of place in the technology sector and generates consistent free cash flow. Add to that a stronger balance sheet, and Core Labs seems like it has a better chance at outperforming Baker Hughes in the coming year, especially if oil prices cool off.

Matthew DiLallo owns shares of Core Laboratories. The Motley Fool recommends Core Laboratories. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Nearly 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Core Laboratories Stock Quote
Core Laboratories
CLB
$21.86 (0.83%) $0.18
Baker Hughes Stock Quote
Baker Hughes
BKR
$29.23 (0.72%) $0.21

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
371%
 
S&P 500 Returns
120%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.